Berlin – Tentamus Group a global product and safety firm, has announced today that Analyst Research Laboratories based in Ness Ziona, is the first Laboratory in Israel that has been awarded the Good Clinical Laboratory Practice (GCLP) accreditation status.
Analyst provides analytical services to the pharmaceutical, biotech, chemical, medical device and medical cannabis industry. The services comply with the strictest demands of regulatory authorities in the USA, Europe and Asia (FDA, EPA, ICH, USP, and OECD). The facilities include over 1,200sqmof modern laboratory and office space in Ness Ziona. A policy of continuous investment in new technology and HR has led to the latest, fully-automated instruments, highly trained personnel and a strong, independent QA unit.
GCLP accreditation now enables Analyst to further support the later stage clinical phases of drug development ensuring customers that all studies will be conducted to GCLP quality standards. GCLP status demonstrates that Analyst operates to a standard that assures the highest reliability, quality and integrity of the work and results generated.
Dr. Vivi Ziv, CEO of Analyst commented, “The accreditation further strengthens our clinical capabilities, enabling us to support regulatory submissions from partners who use our technology and expertise globally”.
Tentamus Group GmbH
An der Industriebahn 5
Contact: Dr. Yvonne Pfeifer
Tel. +49 30 206 038 164